Cargando…

Globalisation of birth markets: a case study of assisted reproductive technologies in India

The escalation of Assisted Reproductive Technologies (ARTs) in India into a veritable fertility industry is the result of a multitude of reasons. This paper places the bio-genetic industry within the larger political economy framework of globalisation and privatisation, thus employing a framework th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarojini, Nadimpally, Marwah, Vrinda, Shenoi, Anjali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Debate
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169454/ https://www.ncbi.nlm.nih.gov/pubmed/21838866 http://dx.doi.org/10.1186/1744-8603-7-27

Ejemplares similares

HIV/AIDS, chronic diseases and globalisation
por: Colvin, Christopher J
Publicado: (2011)

Globalisation, health and foreign policy: emerging linkages and interests
por: Owen, John Wyn, et al.
Publicado: (2005)

European health research and globalisation: is the public-private balance right?
por: McCarthy, Mark
Publicado: (2011)

Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients
por: Bosch, Ernesto, et al.
Publicado: (2011)

First do no harm: uterine natural killer (NK) cells in assisted reproduction
por: Moffett, Ashley, et al.
Publicado: (2015)

Italian law on medically assisted reproduction: do women’s autonomy and health matter?
por: Riezzo, Irene, et al.
Publicado: (2016)

Market failure, policy failure and other distortions in chronic disease markets
por: Watts, Jennifer J, et al.
Publicado: (2009)

Direct marketing in health and medicine: using direct mail, email marketing, and related communicative methods to engage patients
por: Elrod, James K., et al.
Publicado: (2020)

The Risk Controllers: Central Counterparty Clearing in Globalised Financial Markets
por: Norman, Peter
Publicado: (2011)

“The invisible”: Participant's experiences in clinical trials
por: Nadimpally, Sarojini, et al.
Publicado: (2017)

Innovation in regulation of rapidly changing health markets
por: Bloom, Gerald, et al.
Publicado: (2014)

The quality case for information technology in healthcare
por: Bates, David W
Publicado: (2002)

Alcohol marketing versus public health: David and Goliath?
por: Madden, Mary, et al.
Publicado: (2021)

Market viability: a neglected concept in implementation science
por: Proctor, Enola K., et al.
Publicado: (2021)

Network Analysis of Cross-Correlations on Forex Market during Crises. Globalisation on Forex Market
por: Miśkiewicz, Janusz
Publicado: (2021)

Integrated marketing communications: a strategic priority in health and medicine
por: Elrod, James K., et al.
Publicado: (2020)

The law and problematic marketing by private umbilical cord blood banks
por: Murdoch, Blake, et al.
Publicado: (2020)

Market access agreements for pharmaceuticals in Europe: diversity of approaches and underlying concepts
por: Jarosławski, Szymon, et al.
Publicado: (2011)

Who creates the “common market”? The gendered practices of knowledge production in a “European studies” journal
por: Haastrup, Toni, et al.
Publicado: (2022)

Autonomous decisions by couples in reproductive care
por: Matar, Amal, et al.
Publicado: (2020)

Modernising the regulation of medical migration: moving from national monopolies to international markets
por: Epstein, Richard J, et al.
Publicado: (2012)

Formulating productive marketing communications strategy: a major health system’s experience
por: Elrod, James K., et al.
Publicado: (2018)

Target marketing in the health services industry: the value of journeying off the beaten path
por: Elrod, James K., et al.
Publicado: (2018)

Foundational elements of communication in health and medicine: avenues for strengthening the marketing communications mix
por: Elrod, James K., et al.
Publicado: (2020)

US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations
por: Schwarz, Sally W., et al.
Publicado: (2019)

Communication and marketing as tools to cultivate the public's health: a proposed "people and places" framework
por: Maibach, Edward W, et al.
Publicado: (2007)

The ICMJE Recommendations and pharmaceutical marketing – strengths, weaknesses and the unsolved problem of attribution in publication ethics
por: Matheson, Alastair
Publicado: (2016)

23andMe: a new two-sided data-banking market model
por: Stoeklé, Henri-Corto, et al.
Publicado: (2016)

Catalyzing marketing innovation and competitive advantage in the healthcare industry: the value of thinking like an outsider
por: Elrod, James K., et al.
Publicado: (2018)

Regulating digital health technologies with transparency: the case for dynamic and multi-stakeholder evaluation
por: Rodriguez-Villa, Elena, et al.
Publicado: (2019)

Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health
por: Mackey, Tim K, et al.
Publicado: (2013)

Globalisation and environment : preliminary perspectives
Publicado: (1997)

Globalising education : trends and applications
por: Mason, Robin
Publicado: (1998)

Use of country of birth as an indicator of refugee background in health datasets
por: Gibson-Helm, Melanie, et al.
Publicado: (2014)

Medico-legal considerations on “Lotus Birth” in the Italian legislative framework
por: Bonsignore, Alessandro, et al.
Publicado: (2019)

Concealed lung anatomy in Botticelli’s masterpieces The Primavera and The Birth of Venus
por: Lazzeri, Davide
Publicado: (2017)

Economic globalisation and the environment /
Publicado: (1997)

The globalisation of breast cancer
por: Boyle, Peter, et al.
Publicado: (2010)

Society, Differentiation and Globalisation
por: Annandale, Ellen
Publicado: (2017)

Extremely premature birth bioethical decision-making supported by dialogics and pragmatism
por: Kaempf, Joseph W., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9dr8ao95ve0fel330dn0ol53aj